Literature DB >> 23100864

Hypolipidemic effect ofAlpinia galanga (Rasna) andKaempferia galanga (Kachoori).

C R Achuthan1, J Padikkala.   

Abstract

The rhizome of bothAlpinia galanga andKaempferia galanga are widely used in the Ayurvedic system of medicine in the treatment of various inflammatory diseases, diabetes mellitus and obesity. Present study evaluated the hypolipidemic action of the ethanolic extract of these plantsin vivo. The oral administration of the extracts (20mg/day) of bothA. galanga andK. galanga effectively lowered the serum and tissue levels of total cholesterol, triglycerides, phospholipids and significantly increased the serum levels of high density lipoproteins(HDL) in high cholesterol fed white wistar rats over a period of 4 weeks. The results are indicative of these plants in various lipid disorders especially atherosclerosis.

Entities:  

Keywords:  Alpinia galanga; Hypolipidemic effect; Kaempferia galanga

Year:  1997        PMID: 23100864      PMCID: PMC3454038          DOI: 10.1007/BF02867956

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  9 in total

1.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

2.  Microdetermination of plasma phospholipids by trichloroacetic acid precipitation.

Authors:  D B ZILVERSMIT; A K DAVIS
Journal:  J Lab Clin Med       Date:  1950-01

3.  Cardiovascular disease and hyperlipidaemia.

Authors:  R M Krauss; Y A Kesäniemi
Journal:  Curr Opin Lipidol       Date:  1994-08       Impact factor: 4.776

4.  Tissue lactate dehydrogenase isoenzyme patterns in rats fed a hypercholesterolaemic diet.

Authors:  P Seethanathan; P A Kurup
Journal:  Atherosclerosis       Date:  1970 Nov-Dec       Impact factor: 5.162

5.  Antitumour principles from Alpinia galanga.

Authors:  H Itokawa; H Morita; T Sumitomo; N Totsuka; K Takeya
Journal:  Planta Med       Date:  1987-02       Impact factor: 3.352

Review 6.  Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

Authors:  G N Levine; J F Keaney; J A Vita
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245

7.  Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study.

Authors:  E Lindenstrøm; G Boysen; J Nyboe
Journal:  BMJ       Date:  1994-07-02

8.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

Authors:  C B Treasure; J L Klein; W S Weintraub; J D Talley; M E Stillabower; A S Kosinski; J Zhang; S J Boccuzzi; J C Cedarholm; R W Alexander
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245

9.  Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin.

Authors:  K K Soudamini; M C Unnikrishnan; K B Soni; R Kuttan
Journal:  Indian J Physiol Pharmacol       Date:  1992-10
  9 in total
  4 in total

1.  Preliminary study on the effect of a herbal formulation "Deepaniyavati" in hyperlipidemia.

Authors:  P Surana; A Sankhla; P K Dashora
Journal:  Indian J Clin Biochem       Date:  2000-07

Review 2.  Critical Review on Nutritional, Bioactive, and Medicinal Potential of Spices and Herbs and Their Application in Food Fortification and Nanotechnology.

Authors:  Debopriya Mandal; Tanmay Sarkar; Runu Chakraborty
Journal:  Appl Biochem Biotechnol       Date:  2022-10-11       Impact factor: 3.094

3.  Allspice and Clove As Source of Triterpene Acids Activating the G Protein-Coupled Bile Acid Receptor TGR5.

Authors:  Angela Ladurner; Martin Zehl; Ulrike Grienke; Christoph Hofstadler; Nadina Faur; Fátima C Pereira; David Berry; Verena M Dirsch; Judith M Rollinger
Journal:  Front Pharmacol       Date:  2017-07-17       Impact factor: 5.810

4.  The predictive utility of the plant phylogeny in identifying sources of cardiovascular drugs.

Authors:  Emily Guzman; Jeanmaire Molina
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.